Lazanda

Drug West Therapeutics Development, LLC
Total Payments
$254,333
Transactions
1,540
Doctors
611
Companies
2

Payment Trends by Year

Year Amount Transactions Doctors
2021 $4,744 279 114
2019 $65,273 274 169
2018 $70,006 338 154
2017 $114,310 649 302

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $142,000 70 55.8%
Consulting Fee $67,200 23 26.4%
Food and Beverage $28,526 1,407 11.2%
Travel and Lodging $12,939 36 5.1%
Unspecified $3,569 1 1.4%
Education $99.46 3 0.0%

Payments by Type

General
$250,764
1,539 transactions
Research
$3,569
1 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
RADARS Study Depomed, Inc. $3,569 0

Top Doctors Receiving Payments for Lazanda — Page 25

Doctor Specialty Location Total Records
, DO Anesthesiology San Francisco, CA $10.84 1
, M.D Orthopaedic Surgery San Francisco, CA $10.84 1
, M.D Pain Medicine San Francisco, CA $10.84 1
, MD Anesthesiology Kaysville, UT $10.80 1
, MD Radiation Oncology Charleston, SC $10.80 1
, M.D Radiation Oncology Charleston, SC $10.80 1
, MD, PHD Specialist Canton, MI $10.59 2
, MD Internal Medicine Ogden, UT $6.27 1
, MD Physical Medicine & Rehabilitation West Valley City, UT $4.73 1
, M.D Pain Medicine Colton, CA $4.46 1
, MD Addiction Medicine Camarillo, CA $2.28 1
, M.D Pain Medicine Pearl River, NY $1.96 1

About Lazanda

Lazanda is a drug associated with $254,333 in payments to 611 healthcare providers, recorded across 1,540 transactions in the CMS Open Payments database. The primary manufacturer is West Therapeutics Development, LLC.

Payment data is available from 2017 to 2021. In 2021, $4,744 was paid across 279 transactions to 114 doctors.

The most common payment nature for Lazanda is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($142,000, 55.8% of total).

Lazanda is associated with 1 research study, including "RADARS Study" ($3,569).